Tyler-Stone Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-350
Closed -$24K 557
2024
Q2
$24K Hold
350
0.01% 493
2024
Q1
$18.8K Hold
350
0.01% 536
2023
Q4
$18.7K Hold
350
0.01% 514
2023
Q3
$17K Hold
350
0.01% 507
2023
Q2
$21K Buy
+350
New +$19.9K 0.01% 477
2022
Q4
$26K Hold
350
0.02% 412
2022
Q3
$21K Hold
350
0.02% 427
2022
Q2
$20K Hold
350
0.01% 444
2022
Q1
$26K Hold
350
0.01% 433
2021
Q4
$25K Buy
+350
New +$25.4K 0.01% 468

Other funds holding GMED

Tyler-Stone Wealth Management's GMED Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 350 shares — an estimated $24K sold.

Tyler-Stone Wealth Management first reported a position in GMED in Q4 2021 and held it in 10 quarters. The position peaked at $26K in Q4 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 350 Globus Medical shares in Q3 2024, an estimated $24K.
  • Tyler-Stone Wealth Management first reported a position in Globus Medical in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Globus Medical position peaked at $26K in Q4 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.